NET Tumor Humor Benefit

NETumor Humor Benefit

December 1, 2012

“If you’re laughing about it, you’re talking about it.”  Comedic performances by Greg Fitzsimmons, Frangela, Adam Ray, Andie Bolt, Eliana Horeczko, Fortune Feimster and more will be featured during the NEtTumor Humor Benefit at the Westside…

READ MORE
Giving Tuesday

Carcinoid Cancer Foundation Participates in #GivingTuesday

November 26, 2012

Help launch #GivingTuesday™!!  The Carcinoid Cancer Foundation is proud to participate in the first annual #GivingTuesday™ to be held on Tuesday, November 27, 2102. Charities, families, businesses and individuals are coming together to transform…

READ MORE
Ebrahim Delpassand, MD

First U.S. Center to Enroll Patients in International, Multicenter Clinical Trial of Lu-177 Octreotate

November 20, 2012

Excel Diagnostics and Nuclear Oncology Center in Houston, Texas, is the first center in the United States to start recruiting patients in a multicenter randomized clinical trial of Lu-177 Octreotate in patients with progressive midgut carcinoid. …

READ MORE
Eric Liu, MD

Archived Neuroendocrine Tumor Webinar by Dr. Eric Liu Now Available

November 16, 2012

Dr. Eric H. Liu, Director of the Neuroendocrine Center and Director of Surgical Services at Vanderbilt University Medical Center in Tennessee, presented a live webinar on August 22, 2012 entitled Imaging of Neuroendocrine Tumors and Obstacles to Diagnosis.

READ MORE
Cheryl Stanley Simpson

Carcinoid Cancer Foundation Releases New Video Series Beginning with “The ABC’s of Carcinoid/NETs”

October 19, 2012

What is the most common kind of neuroendocrine tumor (NET)?  How do these tumors grow?  What is carcinoid syndrome?  What are the quality of life issues for patients?  In “The ABC’s of Carcinoid/NETs,” three of the world’s leading carcinoid and NET cancer…

READ MORE
Magnus Essand

A Possible Cure for Neuroendocrine Cancer — It Can Be Named for You or a Loved One

September 1, 2012

For $1.6 million (1 million pounds) an oncolytic virus that has the potential to cure neuroendocrine cancer can be named for the donor.  At Uppsala University in Sweden researchers are ready to start a clinical trial for up to 20 NET (neuroendocrine tumor)…

READ MORE
Eric Liu, MD, Vanderbilt University & patient

Neuroendocrine Tumor Webinar Just Opened to Patients and the Public

August 21, 2012

Just opened to the patient community and the public, with limited space available, is a free live webinar featuring carcinoid and NET cancer specialist Dr. Eric Liu, Director of the Neuroendocrine Center at Vanderbilt University Medical Center in Nashville,…

READ MORE
Cycling the C&O for Carcinoid

Cycling the C&O Canal for Carcinoid

August 12, 2012

When Diane and Dwight Mikulis cycle the 184 miles of the Chesapeake & Ohio Canal this summer, they will bring greater awareness to the rare cancer that Diane’s mother, Stella Mae Lux Behers, battled for six years after being diagnosed in 1996. Like …

READ MORE
Ebrahim S. Delpassand, MD, FACNM

FDA Approves Amendment for PRRT Clinical Trial in Texas

August 2, 2012

BREAKING NEWS:  The Food and Drug Administration (FDA) has just approved the RadioIsotope Therapy of America (RITA) Foundation’s amendment to the Investigational New Drug (IND) protocol for intra-hepatic artery administration of Lu-177 Octreotate

READ MORE
Zebra Cartoon, Episode 1

Worldwide NET Cancer Awareness Day Alliance Launches Zebra Cartoon Sequel

July 11, 2012

Global recognition of the need for NET (neuroendocrine tumor) cancer awareness will be marked by the third annual worldwide NET Cancer Day on November 10, 2012.  In anticipation of the day, the Worldwide NET Cancer Awareness Day Alliance has launched…

READ MORE